Jean-Michel Cossery
Chairman chez SCANCELL HOLDINGS PLC
Fortune : 378 167 $ au 31/03/2024
Profil
Jean-Michel Yves Sylvain Cossery is currently the Non-Executive Chairman at Scancell Holdings Plc, Independent Non-Executive Director at Malin Corp.
Plc, Independent Director at SOPHiA GENETICS SA, Director at Malin Life Sciences Holdings Ltd., and Director at EraCal Therapeutics AG.
Previously, he held positions such as Chairman at American Pharmaceutical Group, Non-Executive Director at Diurnal Group Ltd., Director at Wipro GE HealthCare Pvt Ltd., Non-Executive Director at Kymab Ltd., Director at EXACT Therapeutics AS, Director at Kymab Group Ltd., Non-Executive Director at Immunocore Holdings Plc, Director at The Association of the British Pharmaceutical Industry, Vice President-North American Oncology at Eli Lilly & Co., Principal at Novartis, Inc., Chief Marketing Officer & VP-Global Marketing at GE Healthcare Ltd.
(United Kingdom), Principal at EMD Serono, Inc., and Executive Vice President-Global Marketing at Amersham Health.
He holds an MBA from Erasmus University Rotterdam and doctorate degrees from Universite Paris Cite and Université Paris-Saclay.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOPHIA GENETICS SA
0,10% | 15/02/2024 | 63 411 ( 0,10% ) | 312 616 $ | 31/03/2024 |
SCANCELL HOLDINGS PLC
0,05% | 30/11/2023 | 454 720 ( 0,05% ) | 58 877 $ | 31/03/2024 |
EXACT THERAPEUTICS AS
0,04% | 31/12/2022 | 12 000 ( 0,04% ) | 6 673 $ | 31/03/2024 |
Postes actifs de Jean-Michel Cossery
| Sociétés | Poste | Début |
|---|---|---|
| MALIN CORPORATION PLC | Director/Board Member | 16/07/2018 |
| SOPHIA GENETICS SA | Director/Board Member | 15/06/2022 |
| SCANCELL HOLDINGS PLC | Chairman | 01/02/2023 |
EraCal Therapeutics AG
 EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | Director/Board Member | - |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The private company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Director/Board Member | - |
Anciens postes connus de Jean-Michel Cossery
| Sociétés | Poste | Fin |
|---|---|---|
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The private company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Director/Board Member | 01/04/2021 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 01/04/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2018 |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Sales & Marketing | 09/01/2014 |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ | - |
Formation de Jean-Michel Cossery
| Erasmus University Rotterdam | Masters Business Admin |
| Universite Paris Cite | Doctorate Degree |
| Université Paris-Saclay | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MALIN CORPORATION PLC | Health Technology |
| SCANCELL HOLDINGS PLC | Health Technology |
| SOPHIA GENETICS SA | Technology Services |
| EXACT THERAPEUTICS | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Entreprise privées | 12 |
|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
| American Pharmaceutical Group | |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Amersham Health | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Commercial Services |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Wipro GE HealthCare Pvt Ltd.
 Wipro GE HealthCare Pvt Ltd. Information Technology ServicesTechnology Services Wipro GE Healthcare Pvt Ltd. is an information technology company that designs and develops medical equipment. The company was founded on March 14, 1990 and is headquartered in Bangalore, India. | Technology Services |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Malin Life Sciences Holdings Ltd.
Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The private company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Finance |
EraCal Therapeutics AG
EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | Commercial Services |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The private company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Health Technology |
